Work

NTRK fusion-positive cancers and TRK inhibitor therapy

Year: 2018

Type: review

Source: Nature Reviews Clinical Oncology

DOI: 10.1038/s41571-018-0113-0

Authors: Emiliano Cocco, Maurizio Scaltriti, Alexander Drilon

Institutions: Memorial Sloan Kettering Cancer Center, Cornell University, Weill Cornell Medicine

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funders: Cycle for Survival, Puma Biotechnology, Daiichi-Sankyo, National Institutes of Health, Genentech, Ignyta, Loxo Oncology, National Cancer Institute, Daiichi Sankyo Europe

Awards: Understanding tumor addiction to TRK fusions and sensitivity to TRK inhibition, Cancer Center Support Grant

OpenAlex ID: W2896424462

FWCI: 21.87

Cites: 152

Cited by: 1,559

Related to: 10